LeadershipLeadPosNCT04824508
Position of Teamleader and Leadership Performance
A study testing position in people with Leadership, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
Trial summary
Investigation in simulated cardiac arrests. Team leaders are randomly designated. Designated teamleaders are instructed to lead their team from the position of the patient's head or remote from the patient. Read more about this study
- Who is it for?
- Ages 24 years and olderHealthy volunteers can take part
- Conditions the study is for
- Leadership
- What is being tested?
- position
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 151 participants
- Where
- 1 siteSwitzerland
- Study dates
- 1 Mar 2017to 30 Sep 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 24 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Physicians taking part in voluntary workshops
Who cannot join
- refusal to participate and/or being videorecorded
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Effect of the Position of the Teamleader on Quality of Leadership and Team Performance
Investigation in simulated cardiac arrests. Team leaders are randomly designated. Designated teamleaders are instructed to lead their team from the position of the patient's head or remote from the patient.
Read the detailed description
participants: physicians taking part in voluntary simulator-based workshops. Teams of 3-4 are formed. One teammember is randomly allocated as teamleader design: prospective, randomized, single-blind, cross-over intervention: teamleaders are randomized and instructed to lead their team from the conventional position at the patient's head or from a remote hands-off position data analysis: will be performed from videorecordings
- Conditions
- Leadership
- Being tested
- position
- Keywords
- simulation, cardiopulmonary resuscitation, teamleader
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
positionBehavioural
teamleaders are instructed to allocated position
| Study group | Role | What they receive |
|---|---|---|
| Conventional position (head position) | Active comparator | Leaderposition at the patient's head Receives: Behavioral: position |
| Remote position | Active comparator | Leaderposition remote from patient and hands-off Receives: Behavioral: position |
What is being measured
The primary outcome is the main question the study is designed to answer.
Quantity of leadership
Number of leadership utterances made as defined by the adapted Leadership Behaviour Description Questionnaire
Measured: 5 minutes
Secondary outcomes (2)
Hands-on time
Hands-on time during the first 5 minutes of the cardiac arrest
Measured: 5 minutes
Quality of leadership
Type of leadership utterances made as defined by the adapted Leadership Behaviour Description Questionnaire
Measured: 5 minutes
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Apr 2021
- Study start1 Mar 2017
- Primary completion30 Jun 2022
- Study completion30 Sep 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for LeadershipStudies of the same condition, open and under way.
- More trials run by University Hospital, Basel, SwitzerlandThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 151 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Basel, Switzerland
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Stephan Marsch, Principal investigator, University Hospital, Basel, Switzerland
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04824508
- Sponsor's protocol ID
- 4031-Sim
- Acronym
- LeadPos
- Status last verified
- Nov 2022
- First submitted
- 22 Mar 2021
- Last updated
- 15 Nov 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Secondary data can be changed Videorecordings of simulations are strictly confidential and cannot be shared
Study at a glance
From the registry record, last updated by the sponsor on 15 Nov 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of the Position of the Teamleader on Quality of Leadership and Team Performance
- ClinicalTrials.gov ID
- NCT04824508
- Acronym / sponsor ID
- LeadPos / 4031-Sim
- Conditions
- Leadership
- Keywords
- simulation, cardiopulmonary resuscitation, teamleader
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 151 participants (actual)
- Lead sponsor
- University Hospital, Basel, SwitzerlandUniversity, hospital or other
- Study start
- 1 Mar 2017 (actual)
- Primary completion
- 30 Jun 2022 (actual)
- Study completion
- 30 Sep 2022 (actual)
- First posted
- 1 Apr 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Investigation in simulated cardiac arrests. Team leaders are randomly designated. Designated teamleaders are instructed to lead their team from the position of the patient's head or remote from the patient.
Detailed description
participants: physicians taking part in voluntary simulator-based workshops. Teams of 3-4 are formed. One teammember is randomly allocated as teamleader design: prospective, randomized, single-blind, cross-over intervention: teamleaders are randomized and instructed to lead their team from the conventional position at the patient's head or from a remote hands-off position data analysis: will be performed from videorecordings
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Conventional position (head position) | Active comparator | Behavioral: positionLeaderposition at the patient's head |
| Remote position | Active comparator | Behavioral: positionLeaderposition remote from patient and hands-off |
Who may qualify
- Ages
- 24 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Physicians taking part in voluntary workshops
Key exclusion criteria (1 listed)
- refusal to participate and/or being videorecorded
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| positionteamleaders are instructed to allocated position | Behavioural | Conventional position (head position), Remote position |
Primary outcome
Quantity of leadership
Time frame: 5 minutes
Number of leadership utterances made as defined by the adapted Leadership Behaviour Description Questionnaire
2 secondary outcomes
Hands-on time
Time frame: 5 minutes
Quality of leadership
Time frame: 5 minutes
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 15 Nov 2022.
- Individual participant dataSharing planned: No. Secondary data can be changed Videorecordings of simulations are strictly confidential and cannot be shared
Related trials for Leadership
Active, not recruiting
Strategic Thinking and Shaping the Future Training for Midwives' Self-Leadership and Self-Compassion
Self-Leadership, Self-Compassion
Recruiting
Coaching and Leadership in Autism Support Settings
Autism Spectrum Disorder (ASD)
Not yet recruitingObservational study
Validation and Clinical Impact of GLIM Criteria in Patients With Inflammatory Bowel Disease
Inflammatory Bowel Diseases, Crohn Disease
Active, not recruiting
Leadership ThriveCircles
Burnout, Professional Fulfillment
Not yet recruiting
The Efficacy of the iWork.COMP Among Health Care Professionals
Toxic Leadership Styles
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Stephan Marsch principal investigator
University Hospital, Basel, Switzerland
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing position in people with Leadership, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 15 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Quantity of leadership (time frame: 5 minutes). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Nov 2022.